Skip to main content

Rallybio Corp

RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001739410

No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.

Q4 2022 vs. Q3 2022

How the institutions holding Rallybio Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of RLYB: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders53158+6
Shares27.8M754.7K32.3M+5.28M (+19.5%)
Value$402.1M$10.9M$212.3M−$178.9M (−45.7%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Rallybio Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to RLYB in Q4 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC353,376$2.32M0.00%
Caas Capital Management LP261,747$1.72M0.33%
Vontobel Holding Ltd.175,977$1.16M0.01%
Walleye Capital LLC80,094$526.2K0.01%
HarbourVest Partners LLC21,877$143.7K0.05%
State of Tennessee, Treasury Department16,625$109.0K0.00%
Renaissance Technologies LLC13,800$91.0K0.00%
Utah Retirement Systems13,240$87.0K0.00%
Squarepoint Ops LLC13,170$86.5K0.00%
Nisa Investment Advisors, LLC18$00.00%

Sold out (4)

Institutions that held Rallybio Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of RLYB in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Alps Advisors Inc17,576$254.0K
China Universal Asset Management Co., Ltd.301$4.00K
Daiwa Securities Group Inc.94$1.00K
Ellevest, Inc.4$0

Not filed for Q4 2022 yet (1)

Institutions that held Rallybio Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLYB in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
AJU IB Investment Co., Ltd.754,678$10.9M